09:15 AM EST, 03/07/2024 (MT Newswires) -- Health care stocks were mixed pre-bell Thursday as the iShares Biotechnology ETF ( IBB ) was unchanged and the Health Care Select Sector SPDR Fund (XLV) was recently up 0.2%.

Stevanato Group (STVN) was nearly 14% lower after it reported Q4 adjusted earnings of 0.18 euro ($0.20) per diluted share, down from 0.19 euro a year earlier. Analysts polled by Capital IQ expected 0.19 euro.

EyePoint Pharmaceuticals ( EYPT ) was 4% higher after reporting that its Q4 net loss narrowed and revenue increased during the period.

GSK (GSK) was up more than 2% after saying it had received positive results from an interim analysis of a late-stage study of its potential multiple myeloma treatment Blenrep in combination with pomalidomide plus dexamethasone compared with bortezomib plus dexamethasone.